Yield10 Bioscience (NASDAQ:YTEN) announced its quarterly earnings data on Monday. The specialty chemicals company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.06, Bloomberg Earnings reports. Yield10 Bioscience had a negative return on equity of 126.91% and a negative net margin of 1,474.19%. The firm had revenue of $0.32 million during the quarter.
Shares of YTEN stock opened at $1.08 on Tuesday. The firm’s 50 day moving average is $0.92. The company has a debt-to-equity ratio of 0.87, a quick ratio of 4.49 and a current ratio of 4.49. The stock has a market capitalization of $11.99 million, a PE ratio of -1.17 and a beta of 3.21. Yield10 Bioscience has a twelve month low of $0.68 and a twelve month high of $1.77.
An institutional investor recently raised its position in Yield10 Bioscience stock. Renaissance Technologies LLC raised its holdings in Yield10 Bioscience Inc (NASDAQ:YTEN) by 9.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 478,176 shares of the specialty chemicals company’s stock after purchasing an additional 41,500 shares during the period. Renaissance Technologies LLC owned about 3.83% of Yield10 Bioscience worth $463,000 at the end of the most recent quarter. 7.43% of the stock is currently owned by hedge funds and other institutional investors.
Yield10 Bioscience Company Profile
Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.